{"id":"https://openalex.org/W2493952873","doi":"https://doi.org/10.1201/9781420004298","title":"Antiangiogenic Cancer Therapy","display_name":"Antiangiogenic Cancer Therapy","publication_year":2007,"publication_date":"2007-07-25","ids":{"openalex":"https://openalex.org/W2493952873","doi":"https://doi.org/10.1201/9781420004298","mag":"2493952873"},"language":"en","primary_location":{"id":"doi:10.1201/9781420004298","doi":"https://doi.org/10.1201/9781420004298","is_oa":false,"landing_page_url":"https://doi.org/10.1201/9781420004298","pdf_url":null,"source":{"id":"https://openalex.org/S4306463075","display_name":"CRC Press eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320584","host_organization_name":"CRC Press","host_organization_lineage":["https://openalex.org/P4310320584","https://openalex.org/P4310320547"],"host_organization_lineage_names":["CRC Press","Taylor & Francis"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"reference-book"},"volume":null,"type":"reference-entry","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110288702","display_name":"Darren W. Davis","orcid":"https://orcid.org/0000-0001-6407-9430","observed_orcids":["https://orcid.org/0000-0001-6407-9430"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Darren W. Davis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008593691","display_name":"Roy S. Herbst","orcid":"https://orcid.org/0000-0003-2535-5847","observed_orcids":["https://orcid.org/0000-0003-2535-5847"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Roy S. Herbst","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5087376683","display_name":"James L. Abbruzzese","orcid":"https://orcid.org/0000-0001-9223-2965","observed_orcids":["https://orcid.org/0000-0001-9223-2965"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James L. Abbruzzese","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":37,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anti-angiogenic-therapy","display_name":"anti-angiogenic therapy","score":0.968999981880188},{"id":"https://openalex.org/keywords/tumor-angiogenesis","display_name":"tumor angiogenesis","score":0.9950000047683716},{"id":"https://openalex.org/keywords/angiogenesis-inhibitors","display_name":"angiogenesis inhibitors","score":0.7799999713897705},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.8059999942779541},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7459999918937683},{"id":"https://openalex.org/keywords/cancer-therapy","display_name":"cancer therapy","score":0.6159999966621399}],"concepts":[{"id":"https://openalex.org/C2992356464","wikidata":"https://www.wikidata.org/wiki/Q574834","display_name":"Antiangiogenic therapy","level":3,"score":0.7811834216117859},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.7541497945785522},{"id":"https://openalex.org/C2983331546","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer therapy","level":3,"score":0.6534867286682129},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5605881214141846},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5055756568908691},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3852938115596771}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1201/9781420004298","doi":"https://doi.org/10.1201/9781420004298","is_oa":false,"landing_page_url":"https://doi.org/10.1201/9781420004298","pdf_url":null,"source":{"id":"https://openalex.org/S4306463075","display_name":"CRC Press eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320584","host_organization_name":"CRC Press","host_organization_lineage":["https://openalex.org/P4310320584","https://openalex.org/P4310320547"],"host_organization_lineage_names":["CRC Press","Taylor & Francis"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"reference-book"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8371999859809875}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1499321737","https://openalex.org/W2133961327","https://openalex.org/W2036213597","https://openalex.org/W1545179222","https://openalex.org/W2021052565","https://openalex.org/W1989288423","https://openalex.org/W1902142936","https://openalex.org/W2059860479","https://openalex.org/W2021777913","https://openalex.org/W2046918186"],"abstract_inverted_index":{"Top":[0],"Investigators":[1],"Explore":[2],"the":[3,19],"Complexities":[4],"of":[5,11,18,27,49],"Angiogenesis":[6],"Cancer":[7],"Research":[8],"The":[9,47],"targeting":[10],"tumor":[12],"angiogenesis":[13],"has":[14,36],"evolved":[15],"into":[16],"one":[17],"most":[20],"widely":[21],"pursued":[22],"therapeutic":[23],"strategies.":[24],"However,":[25],"as":[26,33],"yet,":[28],"no":[29],"antiangiogenic":[30],"agent":[31],"used":[32],"a":[34,38,42],"monotherapy":[35],"demonstrated":[37],"survival":[39],"benefit":[40],"in":[41],"randomized":[43],"Phase":[44],"III":[45],"trial.":[46],"combination":[48],"bev":[50]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2020,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-08-23T00:00:00"}